Torthaí cuardaigh - Bruce Poppe
- 1 - 20 toradh as 30 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
-
2
-
3
-
4
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes de réir Jo Vandesompele, Katleen De Preter, Filip Pattyn, Bruce Poppe, Nadine Van Roy, Anne De Paepe, Frank Speleman
Foilsithe / Cruthaithe 2002Artigo -
5
Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations de réir Kim De Leeneer, Jan Hellemans, Joachim De Schrijver, Machteld Baetens, Bruce Poppe, Wim Van Criekinge, Anne De Paepe, Paul Coucke, Kathleen Claes
Foilsithe / Cruthaithe 2011Artigo -
6
Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice de réir Wim Terryn, Pierre Cochat, Roseline Froissart, Alberto Ortíz, Yves Pirson, Bruce Poppe, Andreas L. Serra, Wim Van Biesen, Raymond Vanholder, Christoph Wanner
Foilsithe / Cruthaithe 2012Artigo -
7
Rapid detection of VHL exon deletions using real-time quantitative PCR de réir Jasmien Hoebeeck, Rob B. van der Luijt, Bruce Poppe, Els De Smet, Nurten Yigit, Kathleen Claes, Richard Zewald, Gert-Jan de Jong, Anne De Paepe, Frank Speleman, Jo Vandesompele
Foilsithe / Cruthaithe 2004Artigo -
8
Polymorphisms in nonhomologous end‐joining genes associated with breast cancer risk and chromosomal radiosensitivity de réir Petra Willems, Kathleen Claes, Ans Baeyens, Veerle Vandersickel, Joke Werbrouck, Kim De Ruyck, Bruce Poppe, Rudy Van den Broecke, Amin Makar, Emanuela Marras, Gianpaolo Perletti, Hubert Thierens, Anne Vral
Foilsithe / Cruthaithe 2007Artigo -
9
Questioning the Pathogenic Role of the GLA p.Ala143Thr “Mutation” in Fabry Disease: Implications for Screening Studies and ERT de réir Wim Terryn, Raymond Vanholder, Dimitri Hemelsoet, Bart P. Leroy, Wim Van Biesen, Gert De Schoenmakere, Birgitte Wuyts, Kathleen Claes, Julie De Backer, G. De Paepe, Agnes B. Fogo, Marleen Praet, Bruce Poppe
Foilsithe / Cruthaithe 2012Artigo -
10
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma de réir Pascale De Paepe, Mathijs Baens, J. Han van Krieken, Bruno Verhasselt, Michel Stul, Annet Simons, Bruce Poppe, Geneviève Laureys, Paul Brons, Peter Vandenberghe, Frank Speleman, Marleen Praet, Chris De Wolf‐Peeters, Peter Marynen, Iwona Włodarska
Foilsithe / Cruthaithe 2003Artigo -
11
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families de réir Deidra J Osher, Kim De Leeneer, G Michils, Nancy Hamel, Eva Tomiak, Bruce Poppe, Karin Leunen, Eric Legius, Andrew Y. Shuen, E. Smith, Jocelyne Arseneau, Patricia N. Tonin, Gert Matthijs, Kathleen Claes, Marc Tischkowitz, William D. Foulkes
Foilsithe / Cruthaithe 2012Artigo -
12
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer de réir Flavia Zita Francies, Tasha Wainstein, Kim De Leeneer, Alan C. Cairns, Marshall Murdoch, Sarah Nietz, Herbert Cubasch, Bruce Poppe, Tom Van Maerken, Brecht Crombez, Ilse Coene, Robyn Kerr, Jacobus Slabbert, Anne Vral, Amanda Krause, Ans Baeyens, Kathleen Claes
Foilsithe / Cruthaithe 2015Artigo -
13
MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia de réir Evelien Mets, Gert Van Peer, Joni Van der Meulen, Michael Boice, Tom Taghon, Steven Goossens, Pieter Mestdagh, Yves Benoît, Barbara De Moerloose, Nadine Van Roy, Bruce Poppe, Jo Vandesompele, H.-G. Wendel, Pieter Van Vlierberghe, Frank Speleman, Pieter Rondou
Foilsithe / Cruthaithe 2014Artigo -
14
Novel biological insights in T-cell acute lymphoblastic leukemia de réir Kaat Durinck, Steven Goossens, Sofie Peirs, Annelynn Wallaert, Wouter Van Loocke, Filip Matthijssens, Tim Pieters, Gloria Milani, Tim Lammens, Pieter Rondou, Nadine Van Roy, Barbara De Moerloose, Yves Benoît, Jody J. Haigh, Frank Speleman, Bruce Poppe, Pieter Van Vlierberghe
Foilsithe / Cruthaithe 2015Revisão -
15
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia de réir Kaat Durinck, Annelynn Wallaert, Inge Van de Walle, Wouter Van Loocke, Pieter‐Jan Volders, Suzanne Vanhauwaert, Ellen Geerdens, Yves Benoît, Nilmadhab Roy, Bruce Poppe, Jean Soulier, Jan Cools, Pieter Mestdagh, Jo Vandesompele, Pieter Rondou, Pieter Van Vlierberghe, Tom Taghon, Frank Speleman
Foilsithe / Cruthaithe 2014Artigo -
16
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias de réir Frank Speleman, Barbara Cauwelier, Nicole Dastugue, Jan Cools, Bruno Verhasselt, Bruce Poppe, Nadine Van Roy, Jo Vandesompele, Carlos Graux, Anne Uyttebroeck, M. Boogaerts, Barbara De Moerloose, Yves Benoît, Dominik Selleslag, Johan Billiet, A Robert, Françoise Huguet, Peter Vandenberghe, Anne De Paepe, Peter Marynen, A Hagemeijer
Foilsithe / Cruthaithe 2005Artigo -
17
MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia de réir Evelien Mets, Joni Van der Meulen, Gert Van Peer, Michael Boice, Pieter Mestdagh, Inge Van de Walle, Tim Lammens, Steven Goossens, Barbara De Moerloose, Yves Benoît, Nadine Van Roy, Emmanuelle Clappier, Bruce Poppe, Jo Vandesompele, H.-G. Wendel, Tom Taghon, Pieter Rondou, Jean Soulier, Pieter Van Vlierberghe, Frank Speleman
Foilsithe / Cruthaithe 2014Artigo -
18
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia de réir Sofie Peirs, Filip Matthijssens, Steven Goossens, Inge Van de Walle, Katia Ruggero, Charles E. de Bock, Sandrine Degryse, Kirsten Canté-Barrett, Delphine Briot, Emmanuelle Clappier, Tim Lammens, Barbara De Moerloose, Yves Benoît, Bruce Poppe, Jules P.P. Meijerink, Jan Cools, Jean Soulier, Terence H. Rabbitts, Tom Taghon, Frank Speleman, Pieter Van Vlierberghe
Foilsithe / Cruthaithe 2014Artigo -
19
Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA) de réir Nika Schuermans, Dimitri Hemelsoet, Wim Terryn, Sanne Steyaert, Rudy Van Coster, Paul Coucke, Wouter Steyaert, Bert Callewaert, Elke Bogaert, Patrick Verloo, Arnaud Vanlander, Elke Debackere, Jody Ghijsels, Pontus LeBlanc, Hannah Verdin, Leslie Naesens, Filomeen Haerynck, Steven Callens, Bart Dermaut, Bruce Poppe, Jan De Bleecker, Patrick Santens, Paul Boon, Guy Laureys, Tessa Kerre
Foilsithe / Cruthaithe 2022Artigo -
20
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia de réir Joni Van der Meulen, Viraj R. Sanghvi, Konstantinos J. Mavrakis, Kaat Durinck, Fang Fang, Filip Matthijssens, Pieter Rondou, Monica Rosèn, Tim Pieters, Peter Vandenberghe, Éric Delabesse, Tim Lammens, Barbara De Moerloose, Björn Menten, Nadine Van Roy, Bruno Verhasselt, Bruce Poppe, Yves Benoît, Tom Taghon, Ari Melnick, Frank Speleman, Hans‐Guido Wendel, Pieter Van Vlierberghe
Foilsithe / Cruthaithe 2014Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Gene
Genetics
Medicine
Internal medicine
Cancer research
Cancer
Breast cancer
Mutation
Oncology
Pathology
Leukemia
Environmental health
Immunology
Population
Artificial intelligence
Computer science
Genetic testing
Germline mutation
Lymphoblastic Leukemia
Allele
Computational biology
Disease
Exon
Genotype
Phenotype
Single-nucleotide polymorphism
Amplicon
Angiokeratoma
Biochemistry